Literature DB >> 28343168

Potential skin involvement in ALS: revisiting Charcot's observation - a review of skin abnormalities in ALS.

Bastien Paré1, François Gros-Louis1.   

Abstract

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease affecting motor neurons of the brain and spinal cord, leading to progressive paralysis and death. Interestingly, many skin changes have been reported in ALS patients, but never as yet fully explained. These observations could be due to the common embryonic origin of the skin and neural tissue known as the ectodermal germ layer. Following the first observation in ALS patients' skin by Dr Charcot in the 19th century, in the absence of bedsores unlike other bedridden patients, other morphological and molecular changes have been observed. Thus, the skin could be of interest in the study of ALS and other neurodegenerative diseases. This review summarizes skin changes reported in the literature over the years and discusses about a novel in vitro ALS tissue-engineered skin model, derived from patients, for the study of ALS.

Entities:  

Keywords:  amyotrophic lateral sclerosis (ALS); biomarkers; early diagnosis; immunohistochemistry; skin

Mesh:

Substances:

Year:  2017        PMID: 28343168     DOI: 10.1515/revneuro-2017-0004

Source DB:  PubMed          Journal:  Rev Neurosci        ISSN: 0334-1763            Impact factor:   4.353


  7 in total

1.  Patient-derived skin fibroblasts as a model to study frontotemporal lobar degeneration.

Authors:  Dorit Hoffmann; Annakaisa Haapasalo
Journal:  Neural Regen Res       Date:  2022-12       Impact factor: 6.058

2.  Fibroblast bioenergetics to classify amyotrophic lateral sclerosis patients.

Authors:  Csaba Konrad; Hibiki Kawamata; Kirsten G Bredvik; Andrea J Arreguin; Steven A Cajamarca; Jonathan C Hupf; John M Ravits; Timothy M Miller; Nicholas J Maragakis; Chadwick M Hales; Jonathan D Glass; Steven Gross; Hiroshi Mitsumoto; Giovanni Manfredi
Journal:  Mol Neurodegener       Date:  2017-10-24       Impact factor: 14.195

3.  GM604 regulates developmental neurogenesis pathways and the expression of genes associated with amyotrophic lateral sclerosis.

Authors:  William R Swindell; Krzysztof Bojanowski; Mark S Kindy; Raymond M W Chau; Dorothy Ko
Journal:  Transl Neurodegener       Date:  2018-12-03       Impact factor: 8.014

4.  Overlapping Genetic Architecture Between Schizophrenia and Neurodegenerative Disorders.

Authors:  Chunyu Li; Tianmi Yang; Ruwei Ou; Huifang Shang
Journal:  Front Cell Dev Biol       Date:  2021-12-24

5.  Differential subcellular expression of P525LFUS as a putative biomarker for ALS phenoconversion.

Authors:  Maria Caputo; Vincenzo La Bella; Antonietta Notaro
Journal:  Neurol Genet       Date:  2020-02-26

6.  Targeting S100A4 with niclosamide attenuates inflammatory and profibrotic pathways in models of amyotrophic lateral sclerosis.

Authors:  Martina Milani; Eleonora Mammarella; Simona Rossi; Chiara Miele; Serena Lattante; Mario Sabatelli; Mauro Cozzolino; Nadia D'Ambrosi; Savina Apolloni
Journal:  J Neuroinflammation       Date:  2021-06-12       Impact factor: 8.322

7.  TDP-43 Cytoplasmic Translocation in the Skin Fibroblasts of ALS Patients.

Authors:  Miguel A Rubio; Mireia Herrando-Grabulosa; Roser Velasco; Israel Blasco; Monica Povedano; Xavier Navarro
Journal:  Cells       Date:  2022-01-08       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.